BETA DRUGS LIMITED (BETA)

NSE: ₹1,471.70
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 102.01 120.81 50.28 54.35
YOY Revenue Growth % - - - -
Other Income 4.81 5.72 2.51 2.92
Total Income 106.82 126.52 52.78 57.27
Total Expenses + 99.24 118.74 49.41 50.21
Cost of Materials Consumed 57.10 74.47 24.72 22.72
Employee Benefit Expense 9.88 9.89 8.24 9.25
Other Expenses 25.13 24.93 9.35 12.80
Operating Profit 2.77 2.06 0.87 4.14
OPM % 2.7% 1.7% 1.7% 7.6%
Profit Before Tax + 3.01 7.78 3.37 7.06
Tax Expense 3.01 7.78 0.12 1.73
Tax % 100% 100% 3.6% 24.4%
Profit After Tax 0.00 0.00 3.25 5.33
EPS (Basic) 2.12 11.39 3.21 5.26

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Standalone.